Advertisement.

ESALF Projected Dividend Yield

Ord Shs/Eisai Co Ltd ( OTCBB : ESALF )

Eisai is mainly engaged in the research, development, manufacture and sale of pharmaceutical products. Co.'s principal prescription drugs include anticancer agents, anti-Alzheimer's agent, anti-TNF monoclonal antibodies, antiepileptic agents, proton pump inhibitors, neuropathic pain relievers, and other prescription drugs under the name of Halaven®, Lenvima®, Fycompa® and Dayvigo®. Co.'s principal over-the-counter products include Vitamin B2 preparations "Chocola BB," gastrointestinal drugs, anti-allergic drugs and dermatological preparations. Co. operates its business activities in Japan, North America, China, Europe, Middle East, Africa, Oceania, Asia and Latin America.

11 YEAR PERFORMANCE RESULTS

ESALF Dividend History Detail
ESALF Dividend News
ESALF Competitors News

# of Shares: 0

Closing Price: 42.12

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2024	160.00	0%	0	$ 0.00	0.00%
2025	160.00	0%	0	$ 0.00	0.00%
2026	160.00	0%	0	$ 0.00	0.00%
2027	160.00	0%	0	$ 0.00	0.00%
2028	160.00	0%	0	$ 0.00	0.00%
2029	160.00	0%	0	$ 0.00	0.00%
2030	160.00	0%	0	$ 0.00	0.00%
2031	160.00	0%	0	$ 0.00	0.00%
2032	160.00	0%	0	$ 0.00	0.00%
2033	160.00	0%	0	$ 0.00	0.00%
2034	160.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 160.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 160.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend Amount (JPY)
2023	N/A	N/A	Sep 30, 2023	Nov 17, 2023	80.0000
2023	N/A	N/A	Mar 31, 2023	May 29, 2023	80.0000
2023 Total:					160.0000